Skin Inc

MARCH 29, 2024

The acquisition comes amid My Salon Suite's ongoing strategy for growth, which resulted in more than 40 franchise agreements and 43 store openings for the brand in 2023.

Portfolios 40

Portfolios Salon Branding 40

Aesthetic Advancements Institute (AAI)

SEPTEMBER 28, 2023

For practitioners keen on expanding their portfolio and offering cutting-edge procedures, understanding the year’s top tweakments is essential. Widely known brands like Botox, Dysport, and Xeomin, while traditionally associated with wrinkle reduction, now focus on subtle enhancements like elevating eyebrows and softening jawlines.

Chemical Peels 36

Chemical Peels Treatments Microneedling Portfolios 36

The Dermatology Digest

MARCH 27, 2024

Stern will join the global leadership team and will be responsible for leading the portfolio and brand strategies. s global brand, where she oversaw product development, media strategies, digital initiatives and integrated marketing efforts, while championing digital equity strategies.

Office 36

Office Portfolios Branding Marketing 36

Spa Executive

NOVEMBER 10, 2023

As global vice president of wellbeing, she will develop and deepen the wellness experience across Auberge Resorts Collection’s portfolio. We asked Vivianne Garcia-Tunon about her new role, her plans for the Auberge wellbeing brand, and what makes the best wellness experiences. What are you most excited about?

Portfolios 52

Portfolios Hospital Partnerships Branding 52

Spa Executive

JANUARY 16, 2024

The Group recently created the brand new role to solidify a renewed focus on wellness. Prior to stepping into this position in June 2023, Ms. Niamh O’Connell is Jumeirah Group’s new Vice President of Wellbeing. We asked Niamh O’Connell about her new role, the global wellness industry, and what makes the best guest experience.

Hospital 52

Hospital Technology Portfolios Branding 52

The Dermatology Digest

DECEMBER 21, 2023

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year.

Marketing 36

Marketing Sales Branding Portfolios 36

The Dermatology Digest

DECEMBER 21, 2023

and Europe of four unique dermal fillers in late-stage development with anticipated regulatory clearances in the second half of 2024 and commercialization under the brand name Estyme (pronounced “esteem”) fillers in 2025. Evolus, Inc. This marks the second agreement Evolus has made with Symatese this year.

Marketing 36

Marketing Sales Branding Portfolios 36